Search

Author/Creator Roth, Michael D

1. Peripheral blood gene expression profiling shows predictive significance for response to mycophenolate in systemic sclerosis-related interstitial lung disease. Issue 6 (21st February 2022)

Authors:
Assassi, Shervin; Volkmann, Elizabeth R; Zheng, W Jim; Wang, Xuan; Wilhalme, Holly; Lyons, Marka A; Roth, Michael D; Tashkin, Donald P
Journal:
Annals of the rheumatic diseases
Issue:
Volume 81:Issue 6(2022)
Page Start:
854
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts. Issue 1 (8th November 2018)

Authors:
Volkmann, Elizabeth R; Tashkin, Donald P; Sim, Myung; Li, Ning; Goldmuntz, Ellen; Keyes-Elstein, Lynette; Pinckney, Ashley; Furst, Daniel E; Clements, Philip J; Khanna, Dinesh; Steen, Virginia; Schraufnagel, Dean E; Arami, Shiva; Hsu, Vivien; Roth, Michael D; Elashoff, Robert M; Sullivan, Keith M
Other Names:
Clements PJ author non-byline.; Tashkin DP author non-byline.; Elashoff R author non-byline.; Goldin J author non-byline.; Roth M author non-byline.; Furst D author non-byline.; Bulpitt K author non-byline.; Khanna D author non-byline.; Chung W-LJ author non-byline.; Viasco S author non-byline.; ...
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78:Issue 1(2019)
Page Start:
122
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Sex differences in clinical outcomes and biological profiles in systemic sclerosis-associated interstitial lung disease: a post-hoc analysis of two randomised controlled trials. (October 2022)

Authors:
Volkmann, Elizabeth R; Tashkin, Donald P; Silver, Richard; Bostwick, Carol Feghali; Assassi, Shervin; Baker Frost, DeAnna; Leng, Mei; Wilhalme, Holly; Kim, Grace Hyun; Goldin, Jonathan; Roth, Michael D
Journal:
Lancet
Issue:
Volume 4:Number 10(2022)
Page Start:
e668
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Transitions to different patterns of interstitial lung disease in scleroderma with and without treatment. Issue 7 (12th January 2016)

Authors:
Kim, Hyun J; Tashkin, Donald P; Gjertson, David W; Brown, Matthew S; Kleerup, Eric; Chong, Semin; Belperio, John A; Roth, Michael D; Abtin, Fereidoun; Elashoff, Robert; Tseng, Chi-Hong; Khanna, Dinesh; Goldin, Jonathan G
Journal:
Annals of the rheumatic diseases
Issue:
Volume 75:Issue 7(2016)
Page Start:
1367
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis. Issue 12 (7th May 2007)

Authors:
Clements, Philip J; Roth, Michael D; Elashoff, Robert; Tashkin, Donald P; Goldin, Jonathan; Silver, Richard M; Sterz, Mildred; Seibold, James R; Schraufnagel, Dean; Simms, Robert W; Bolster, Marcy; Wise, Robert A; Steen, Virginia; Mayes, M D; Connelly, Kari; Metersky, Mark; Furst, Daniel E
Journal:
Annals of the rheumatic diseases
Issue:
Volume 66:Issue 12(2007)
Page Start:
1641
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Issue 9 (September 2016)

Authors:
Tashkin, Donald P; Roth, Michael D; Clements, Philip J; Furst, Daniel E; Khanna, Dinesh; Kleerup, Eric C; Goldin, Jonathan; Arriola, Edgar; Volkmann, Elizabeth R; Kafaja, Suzanne; Silver, Richard; Steen, Virginia; Strange, Charlie; Wise, Robert; Wigley, Fredrick; Mayes, Maureen; Riley, David J; H...
Journal:
Lancet
Issue:
Volume 4:Issue 9(2016)
Page Start:
708
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗